Scenarios that move ARVN

Arvinas, Inc. - Common Stock

Scenarios that move ARVN: 1 analysis, 1 positive, 0 negative.

  1. · AstraZeneca's Etcamah fails late-stage study in first-line breast cancer — ▲ · impact +38 · confidence low · horizon immediate

All scenarios · Run a scenario · Pricing